Brief: Pharmaust Ltd Says Chief Executive Officer Michael Thurn, Has Tendered His Resignation
23/04/2024 02:15
April 23 (Reuters) - Pharmaust Ltd PAA.AX :
* CHIEF EXECUTIVE OFFICER DR MICHAEL THURN, HAS TENDERED HIS
RESIGNATION
* JOHN CLARK APPOINTED INTERIM CEO.
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility